Price $51.32 |
Market Cap
6.67B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
257.9
|
P/B
31.17
|
P/S
13.83
|
Dividend %
-
|
|
P/CF
334.4
|
P/FCF
62.4
|
Op. Cash Flow
122.5K
|
FCF
0.8
|
|
Op. Margin
13.50%
|
Net Margin
5.20%
|
ROE
15.50%
|
ROI
-7.70%
|
|
ROA
2.60%
|
EPS Growth
111.20%
|
Current Ratio
6.0
|
Debt/Equity
590.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Veru Inc (VERU) | $2.17 | - | - | 85.7M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $1.46 | - | - | 42.8M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.72 | - | - | 4.6M | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
